StockNews.com started coverage on shares of LifeVantage (NASDAQ:LFVN – Get Rating) in a research note released on Monday. The brokerage issued a buy rating on the stock.
LifeVantage Stock Performance
Shares of NASDAQ:LFVN opened at $3.79 on Monday. LifeVantage has a fifty-two week low of $3.59 and a fifty-two week high of $7.70. The company's 50-day moving average is $4.06 and its 200 day moving average is $4.35. The company has a market capitalization of $47.58 million, a P/E ratio of 15.79 and a beta of 1.22.
Get
LifeVantage alerts:
LifeVantage Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 15th. Investors of record on Friday, September 2nd were paid a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 3.17%. The ex-dividend date was Thursday, September 1st. LifeVantage's dividend payout ratio is currently 50.00%.
Institutional Investors Weigh In On LifeVantage
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in LFVN. Dimensional Fund Advisors LP raised its stake in LifeVantage by 5.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 259,650 shares of the company's stock valued at $1,641,000 after acquiring an additional 12,720 shares during the period. O Shaughnessy Asset Management LLC increased its position in shares of LifeVantage by 49.8% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 23,461 shares of the company's stock valued at $148,000 after buying an additional 7,804 shares during the period. Victory Capital Management Inc. increased its position in shares of LifeVantage by 30.4% during the first quarter. Victory Capital Management Inc. now owns 13,868 shares of the company's stock valued at $66,000 after buying an additional 3,235 shares during the period. Campbell & CO Investment Adviser LLC increased its position in shares of LifeVantage by 117.2% during the first quarter. Campbell & CO Investment Adviser LLC now owns 21,717 shares of the company's stock valued at $103,000 after buying an additional 11,717 shares during the period. Finally, American Century Companies Inc. increased its position in shares of LifeVantage by 30.3% during the first quarter. American Century Companies Inc. now owns 46,016 shares of the company's stock valued at $219,000 after buying an additional 10,706 shares during the period. 27.06% of the stock is currently owned by institutional investors.
About LifeVantage
(Get Rating)
LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes.
Featured Stories
- Get a free copy of the StockNews.com research report on LifeVantage (LFVN)
- The Worst May be Over for Target, But is the Stock Safe to Buy?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Two Fun Stocks The Insiders Are Buying
- Novavax Remains a Risk-On Stock in a Risk-Off Market
- 3 Defensive Stocks With 60-Year Dividend Hike Streaks
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.
